We represented WellCare Health Plans, Inc. in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion. The combined company will serve more than 24 million members in all 50 states and will be headquartered in St. Louis, Missouri, though it will still maintain operations in Tampa, Florida, where WellCare is currently headquartered.
The transaction was highlighted in several media outlets, including:
- “Centene-WellCare Megamerger Closes,” HealthLeaders (January 23, 2020)
- “Centene Completes Acquisition of WellCare, Creating a Leading Healthcare Enterprise Focused on Government-Sponsored Healthcare Programs,” PR Newswire (January 23, 2020)
- “Centene, WellCare Merger Nears Finish Line,” Modern Healthcare (January 22, 2020)
This transaction was named a winner in the following two categories for the 19th Annual M&A Advisor Awards in 2020: “Healthcare and Life Sciences Deal of the Year (Over $1B)” and “Corporate/Strategic Deal of the Year (Over $1B).” Additionally, this transaction was named a finalist in the “Healthcare, Pharma & Biotech – Deal (Large Cap) category” for The Deal Awards 2021.
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals.
WellCare Health Plans, Inc. (Formerly NYSE: WCG) focuses primarily on providing government-sponsored managed care services to families, children, seniors and individuals with complex medical needs primarily through Medicaid, Medicare Advantage and Medicare Prescription Drug Plans, as well as individuals in the Health Insurance Marketplace.